OMVKY yields 7.31% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, OMVKY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OMVKY + JNJ for your $10,000?
OMV Aktiengesellschaft operates as an energy and chemicals company in Austria, Germany, Romania, Norway, New Zealand, the United Arab Emirates, the rest of Central and Eastern Europe, the rest of Europe, and internationally. The company operates through Exploration & Production, Refining & Marketing, and Chemicals & Materials segments. The Exploration & Production segment engages in the exploration, development, and production of oil and gas in the regions of Central and Eastern Europe, the Middle East and Africa, the North Sea, and the Asia Pacific. The Refining & Marketing segment is involved in the refining and marketing of fuels and other feedstock. It has 3 inland refineries in Europe; approximately 2,100 filling stations in ten European countries; and gas storage facilities in Austria and Germany, as well as a gas-fired power plant in Romania. This segment is also involved in the supply, marketing, and trading of gas in Europe and Turkey. The Chemicals & Materials segment provides advanced and circular polyolefin solutions, base chemicals, and fertilizers, as well as engages in the recycling of plastics. The company was founded in 1956 and is headquartered in Vienna, Austria.
Full OMVKY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.